Schlottmann K, Gelbmann C, Grüne S, Lock G, Schölmerich J
Klinik und Poliklinik für Innere Medizin I, Universitätsklinikum Regensburg.
Med Klin (Munich). 2001 Jun 15;96(6):321-4. doi: 10.1007/s00063-001-1053-4.
Diagnostic or therapeutic paracentesis of ascites or pleural effusions is part of the daily routine on many hospital wards and in outpatient clinics. In Germany, paracentesis is usually performed with angiocaths. However, the therapeutic large volume paracentesis of ascites and paracentesis of pleural effusions with angiocaths is often cumbersome and quite often paracentesis fails, forcing the physician to repuncture. This is mainly due to the fact that angiocaths are not designed for such interventions.
45 patients with ascites or pleural effusions were treated with a new needle specially designed for paracentesis, or with an angiocath. The new paracentesis needle was compared with the angiocath needle under the following aspects: necessity and number of positional corrections of the needle, necessity of and reasons for repuncture, duration of puncture, flow capacity, subjective practicability of paracentesis and patient acceptance of the paracentesis needle.
The paracentesis needle was superior to the angiocath in all investigated respects. Significantly, the paracentesis needle had a much higher success rate in the complete drainage than had the angiocath.
The paracentesis needle was objectively superior as compared to the angiocath. It might help to avoid additional complications due to repuncture and it will increase the patients' comfort.
腹水或胸腔积液的诊断性或治疗性穿刺术是许多医院病房和门诊日常工作的一部分。在德国,穿刺术通常使用血管穿刺导管进行。然而,使用血管穿刺导管进行治疗性大量腹水穿刺术和胸腔积液穿刺术往往很麻烦,而且穿刺术常常失败,迫使医生重新穿刺。这主要是因为血管穿刺导管并非为此类干预设计。
45例腹水或胸腔积液患者分别使用一种专门为穿刺术设计的新型穿刺针或血管穿刺导管进行治疗。将新型穿刺针与血管穿刺导管针在以下方面进行比较:穿刺针位置校正的必要性和次数、重新穿刺的必要性及原因、穿刺持续时间、流量、穿刺术的主观实用性以及患者对穿刺针的接受程度。
在所有调查方面,穿刺针均优于血管穿刺导管针。值得注意的是,穿刺针在完全引流方面的成功率远高于血管穿刺导管针。
与血管穿刺导管针相比,穿刺针在客观上更具优势。它可能有助于避免因重新穿刺导致的额外并发症,并会提高患者的舒适度。